EcoDrugPlus

Ensembl ID : ENSPCTG00005016393
Gene Symbol: -
Cross references: -
149 Possible Orthologues:

Ensembl ID : ENSPCTG00005015765
Gene Symbol: -
Cross references: -
172 Possible Orthologues:

Ensembl ID : ENSPCTG00005018576
Gene Symbol: -
Cross references: -
181 Possible Orthologues:

Ensembl ID : ENSPCTG00005019238
Gene Symbol: -
Cross references: -
147 Possible Orthologues:

Ensembl ID : ENSPCTG00005020371
Gene Symbol: -
Cross references: -
118 Possible Orthologues:

Ensembl ID : ENSPCTG00005020793
Gene Symbol: -
Cross references: -
123 Possible Orthologues:

Ensembl ID : ENSPCTG00005020348
Gene Symbol: -
Cross references: -
205 Possible Orthologues:

Ensembl ID : ENSPCTG00005020313
Gene Symbol: -
Cross references: -
205 Possible Orthologues:

Ensembl ID : ENSPCTG00005001193
Gene Symbol: -
Cross references: -
263 Possible Orthologues:

Ensembl ID : ENSPCTG00005013997
Gene Symbol: -
Cross references: -
563 Possible Orthologues:

Ensembl ID : ENSPCTG00005020877
Gene Symbol: -
Cross references: -
128 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).